KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bausch Health Companies (BHC) Return on Sales (2016 - 2025)

Bausch Health Companies (BHC) has disclosed Return on Sales for 17 consecutive years, with 0.04% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 8.0% to 0.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, up 2.0% year-over-year, with the annual reading at 0.01% for FY2025, 2.0% up from the prior year.
  • Return on Sales hit 0.04% in Q4 2025 for Bausch Health Companies, down from 0.07% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.2% in Q3 2022 to a low of 0.3% in Q1 2021.
  • Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.04% in 2022.
  • Biggest five-year swings in Return on Sales: grew 27bps in 2022 and later crashed -37bps in 2023.
  • Year by year, Return on Sales stood at 0.01% in 2021, then plummeted by -1980bps to 0.19% in 2022, then surged by 90bps to 0.02% in 2023, then skyrocketed by 296bps to 0.04% in 2024, then tumbled by -196bps to 0.04% in 2025.
  • Business Quant data shows Return on Sales for BHC at 0.04% in Q4 2025, 0.07% in Q3 2025, and 0.05% in Q2 2025.